Daxor Corporation

NasdaqCM DXR

Daxor Corporation Dividend Yield on January 14, 2025

Daxor Corporation Dividend Yield is NA on January 14, 2025, a NA change year over year. Dividend yield measures the dividend per share relative to stock's price value; higher yield suggests higher dividend return.

Daxor Corporation 52-week high Dividend Yield is NA on January 14, 2025, which is NA below the current Dividend Yield.
Daxor Corporation 52-week low Dividend Yield is NA on January 14, 2025, which is NA below the current Dividend Yield.
Daxor Corporation average Dividend Yield for the last 52 weeks is NA.

Key data

Date	Dividend Yield	Free Cash Flow Yield	Earnings Yield	Enterprise Value (EV)

NasdaqCM: DXR

Daxor Corporation

CEO	Mr. Michael Richard Feldschuh
IPO Date	July 25, 1983
Location	United States
Headquarters	109 Meco Lane
Employees	37
Sector	Health Care
Industries Medical Instruments Biotechnology Pharmaceuticals

Description

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee.

Key trends

Past 5 years